story of the week
First-Dose ChAdOx1 and BNT162b2 COVID-19 Vaccines and Thrombocytopenic, Thromboembolic, and Hemorrhagic Events
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
First-Dose ChAdOx1 and BNT162b2 COVID-19 Vaccines and Thrombocytopenic, Thromboembolic and Hemorrhagic Events in Scotland
Nat. Med. 2021 Jun 09;[EPub Ahead of Print], CR Simpson, T Shi, E Vasileiou, SV Katikireddi, S Kerr, E Moore, C McCowan, U Agrawal, SA Shah, LD Ritchie, J Murray, J Pan, DT Bradley, SJ Stock, R Wood, A Chuter, J Beggs, HR Stagg, M Joy, RSM Tsang, S de Lusignan, R Hobbs, RA Lyons, F Torabi, S Bedston, M O'Leary, A Akbari, J McMenamin, C Robertson, A SheikhFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.